サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1801245

血栓管理デバイスの市場規模、シェア、動向、製品タイプ別、エンドユーザー別、地域別、2025～2033年予測

Clot Management Devices Market Size, Share, Trends and Forecast by Product Type, End-User, and Region, 2025-2033

出版日
発行
IMARC
ページ情報
英文 122 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=149.25円
血栓管理デバイスの市場規模、シェア、動向、製品タイプ別、エンドユーザー別、地域別、2025～2033年予測
出版日: 2025年08月01日
発行: IMARC
ページ情報: 英文 122 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

血栓管理デバイスの世界市場規模は2024年に19億米ドルとなりました。今後、IMARC Groupは、市場は2033年までに29億米ドルに達し、2025～2033年にかけて4.58%のCAGRを示すと予測しています。現在、北米が市場を独占しており、2024年には55.3％を超える大きな市場シェアを占めています。心血管疾患の有病率の上昇、人口の高齢化、低侵襲手術の需要の増加、技術の進歩などが、血栓管理デバイス市場シェアに拍車をかけている主要因です。

血栓管理デバイス市場は、深部静脈血栓症、心血管疾患、脳卒中、肺塞栓症の有病率の上昇によって牽引されており、効果的な血栓除去ソリューションの需要が高まっています。血栓性疾患に罹患しやすい高齢者が急速に増加していることも、市場をさらに活性化させています。低侵襲手技技術の進歩により、入院期間や回復期間が短縮され、患者の転帰が改善されます。血栓の早期発見・治療に対する意識の高まりと有利な償還プラクティスが採用を後押ししています。さらに、ヘルスケア支出の増加、先進医療技術に対する政府の支援、専門治療センターの拡大も市場成長に寄与しています。また、主要医療機器メーカーの存在や革新的な血栓除去技術の研究が進んでいることも産業の競合情勢を後押ししています。

米国の血栓管理デバイス市場は、深部静脈血栓症、心血管疾患、肺塞栓症の高い有病率によって牽引されています。同国の先進的ヘルスケアインフラ、低侵襲手技の採用増加、大手医療機器メーカーの存在感が市場成長に寄与しています。好意的な償還施策と高いヘルスケア支出が、先進治療へのアクセスを高めています。さらに、血栓の早期発見に関する意識の高まり、高齢者の増加、血栓除去装置の技術進歩が需要を後押ししています。例えば、2025年1月、Argon Medical Devicesは、肺塞栓症（PE）と診断された患者の肺から血栓を摘出するCleaner Pro血栓摘出システムの安全性と有効性を評価するCLEAN-PE検査の最初の患者登録を報告しました。CLEAN-PEには、米国内のさまざまな病院で100人以上の患者が登録される見込みです。政府の支援、継続的な研究開発、外来手術の増加が米国での市場拡大をさらに後押ししています。

血栓管理デバイス市場動向

心血管疾患と血栓性疾患の有病率の上昇

心血管疾患、脳卒中、深部静脈血栓症、肺塞栓症の罹患率の増加は、血栓管理デバイス市場の主要な促進要因です。座りがちなライフスタイル、肥満、喫煙、高血圧が血栓症患者の増加に寄与しており、効果的な治療ソリューションが必要とされています。世界人口の高齢化は血栓性障害のリスクをさらにエスカレートさせ、先進的血栓除去技術への需要を高めています。最近の産業レポートによると、2024年には世界人口の12％が60歳以上で、12億人に相当します。この数は2050年までに21億人に増加し、世界総人口の26％を占めると予想されています。早期診断と早期介入に対する意識の高まりにより、病院や専門クリニックでの血栓管理デバイスの導入が進んでいます。このような疾病負担の増加が、革新的な血栓除去技術の研究開発と商業化を後押しし続けています。

血栓管理デバイスの技術的進歩

経皮的血栓除去システム、カテーテル直接血栓溶解療法、機械的血栓除去装置など、血栓管理デバイスにおける現在進行中の技術革新は、患者の治療に革命をもたらしています。これらの進歩により、低侵襲の手技が可能となり、患者の転帰を改善しながら回復時間と入院期間を短縮することができます。最新の血栓除去装置は精度と効率を高め、手技をより安全で効果的なものにしています。人工知能、ロボット工学、リアルタイム画像は、血栓除去技術の向上にさらに貢献しています。ヘルスケアプロバイダがより良く、より早く、より安全な治療法を求める中、継続的な製品開発と規制当局の承認が先進的血栓管理技術の採用を後押ししています。例えば、2024年9月、末梢静脈血管から血栓を除去することを目的としたCLEANER VacTM Thrombectomy Systemが、インターベンショナルラジオロジー、血管外科、インターベンショナルカーディオロジー、腫瘍学的処置のための医療機器ソリューションの主要プロバイダであるArgon Medical Devicesから発表されました。CLEANER Vac Thrombectomy Systemと呼ばれるシングルユースの大口径吸引ツールは、血流が制限された静脈から血栓として知られる血栓を迅速かつ効果的に除去するために開発されました。

好意的なヘルスケア施策と償還支援

政府の支援施策と償還の枠組みは、先進的血栓管理治療をより身近なものにすることで、血栓管理デバイス市場の前向きな展望を生み出しています。米国を含む多くの国では、血栓摘出術に有利な保険適用を提供しており、より多くの病院や医療提供者がこれらの技術を採用することを奨励しています。FDAなどの規制当局による承認や、新しい血栓管理デバイスに対するCEマーク認証は、市場拡大をさらに後押しします。例えば、2023年3月、Penumbraは、画期的な動脈血栓除去システムであるLightning Bolt 7の導入について食品医薬品局から承認を受けた。この技術は、圧力センサとアルゴリズムを採用し、装置が血液を吸引しているのか血栓を吸引しているのかを判断し、吸引量を調節して血栓を除去します。ペナンブラ社（本社：カリフォルニア州アラメダ）は、ライトニングボルト7と最近導入されたライトニングフラッシュにより、2023年の売上高が23％から25％増加すると見込んでいます。さらに、ヘルスケア支出の増加と医療インフラへの投資は、メーカーが革新的な血栓管理ソリューションを導入する機会を創出し、救命治療への幅広い患者アクセスを保証します。

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界の血栓管理デバイス市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品タイプ別

  • 神経血管塞栓除去デバイス
  • 塞栓摘出バルーンカテーテル
  • 経皮的血栓除去デバイス
    • 主要タイプ
      • 機械的血栓除去術
      • 吸引血栓除去術
      • 経皮的機械的血栓除去術（PMT）
  • カテーテル誘導血栓溶解デバイス
  • 下大静脈フィルター
    • 主要タイプ
      • 永続型
      • 取出型

第7章 市場内訳：エンドユーザー別

  • 病院
  • 診断センターと専門クリニック

第8章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ

第9章 SWOT分析

第10章 バリューチェーン分析

第11章 ポーターのファイブフォース分析

第12章 価格指標

第13章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • AngioDynamics Inc.
    • Argon Medical Devices Inc.
    • Boston Scientific Corporation
    • DePuy Synthes Inc.
    • Edwards Lifesciences Corporation
    • iVascular S.L.U.
    • Lemaitre Vascular Inc.
    • Medtronic Inc.
    • Straub Medical AG
    • Stryker Corporation
    • Teleflex Incorporated
    • Vascular Solutions
図表

List of Figures

  • Figure 1: Global: Clot Management Devices Market: Major Drivers and Challenges
  • Figure 2: Global: Clot Management Devices Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Clot Management Devices Market: Breakup by Product Type (in %), 2024
  • Figure 4: Global: Clot Management Devices Market: Breakup by End-User (in %), 2024
  • Figure 5: Global: Clot Management Devices Market: Breakup by Region (in %), 2024
  • Figure 6: Global: Clot Management Devices Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 7: Global: Clot Management Devices (Neurovascular Embolectomy Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 8: Global: Clot Management Devices (Neurovascular Embolectomy Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 9: Global: Clot Management Devices (Embolectomy Balloon Catheters) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Clot Management Devices (Embolectomy Balloon Catheters) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Clot Management Devices (Percutaneous Thrombectomy Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Clot Management Devices (Percutaneous Thrombectomy Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Clot Management Devices (Catheter-Directed Thrombolysis Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Clot Management Devices (Catheter-Directed Thrombolysis Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Clot Management Devices (Inferior Vena Cava Filters) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Clot Management Devices (Inferior Vena Cava Filters) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Clot Management Devices (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Clot Management Devices (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Clot Management Devices (Diagnostic Centers and Specialty Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Clot Management Devices (Diagnostic Centers and Specialty Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: North America: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: North America: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: United States: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: United States: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Canada: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Canada: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Asia Pacific: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Asia Pacific: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: China: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: China: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Japan: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Japan: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: India: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: India: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: South Korea: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: South Korea: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Australia: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Australia: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Indonesia: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Indonesia: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Others: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Others: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Europe: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Europe: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Germany: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Germany: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: France: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: France: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: United Kingdom: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: United Kingdom: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Italy: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Italy: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Spain: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Spain: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Russia: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Russia: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Others: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Others: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Latin America: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Latin America: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Brazil: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Brazil: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Mexico: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Mexico: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Others: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Others: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Middle East and Africa: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Middle East and Africa: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Global: Clot Management Devices Industry: SWOT Analysis
  • Figure 70: Global: Clot Management Devices Industry: Value Chain Analysis
  • Figure 71: Global: Clot Management Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Clot Management Devices Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Clot Management Devices Market Forecast: Breakup by Product Type (in Million USD), 2025-2033
  • Table 3: Global: Clot Management Devices Market Forecast: Breakup by End-User (in Million USD), 2025-2033
  • Table 4: Global: Clot Management Devices Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 5: Global: Clot Management Devices Market Structure
  • Table 6: Global: Clot Management Devices Market: Key Players
目次
Product Code: SR112025A2131

The global clot management devices market size was valued at USD 1.90 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 2.90 Billion by 2033, exhibiting a CAGR of 4.58% during 2025-2033. North America currently dominates the market, holding a significant market share of over 55.3% in 2024. The rising prevalence of cardiovascular diseases, an aging population, increasing demand for minimally invasive procedures, and technological advancements are some of the key factors fueling the clot management devices market share.

The market for clot management devices is driven by the rising prevalence of deep vein thrombosis, cardiovascular diseases, stroke, and pulmonary embolism, which increase the demand for effective clot removal solutions. A rapidly increasing geriatric population, more susceptible to thrombotic disease, fuels the market further. Advances in technology for minimally invasive procedures improve patient outcomes with shorter hospital stays and recovery periods. Greater awareness of early detection and treatment of clots and favorable reimbursement practices drive adoption. Additionally, rising healthcare expenditures, government support for advanced medical technologies, and the expansion of specialized treatment centers contribute to market growth. The presence of key medical device manufacturers and ongoing research into innovative thrombectomy techniques also drive the industry's competitive landscape.

The market for clot management devices in the United States is driven by the high prevalence of deep vein thrombosis, cardiovascular diseases, and pulmonary embolism. The country's advanced healthcare infrastructure, increasing adoption of minimally invasive procedures, and strong presence of leading medical device manufacturers contribute to market growth. Favorable reimbursement policies and high healthcare spending enhance access to advanced treatments. Additionally, rising awareness about early clot detection, a growing geriatric population, and technological advancements in thrombectomy devices fuel demand. For instance, in January 2025, Argon Medical Devices reported the initial patient enrollment in the CLEAN-PE study, which seeks to assess the safety and effectiveness of the Cleaner Pro thrombectomy system for extracting blood clots from the lungs of patients diagnosed with pulmonary embolism (PE). It is anticipated that more than 100 patients are enrolled in CLEAN-PE at different hospitals throughout the United States. Government support, ongoing research and development, and an increasing number of outpatient procedures further propel the market's expansion in the U.S.

Clot Management Devices Market Trends:

Rising Prevalence of Cardiovascular Diseases and Thrombotic Disorders

The increasing incidence of cardiovascular diseases, stroke, deep vein thrombosis, and pulmonary embolism is a major driver of the clot management devices market. Sedentary lifestyles, obesity, smoking, and hypertension contribute to higher cases of blood clots, necessitating effective treatment solutions. An aging global population further escalates the risk of thrombotic disorders, increasing demand for advanced clot removal technologies. According to recent industry reports, in 2024, 12% of the global population was aged 60 years and above, equating to 1.2 Billion individuals. This number is expected to rise to 2.1 Billion by 2050, making up 26% of the total population in the world. The growing awareness about early diagnosis and intervention has led to higher adoption of clot management devices in hospitals and specialized clinics. This rising disease burden continues to push the research, development, and commercialization of innovative clot removal technologies.

Technological Advancements in Clot Management Devices

Ongoing innovations in clot management devices, such as percutaneous thrombectomy systems, catheter-directed thrombolysis, and mechanical thrombectomy devices, are revolutionizing patient care. These advancements allow for minimally invasive procedures, reducing recovery time and hospital stays while improving patient outcomes. Modern thrombectomy devices offer enhanced precision and efficiency, making procedures safer and more effective. Artificial intelligence, robotics, and real-time imaging further contribute to improved clot removal techniques. As healthcare providers seek better, faster, and safer treatment options, continuous product development and regulatory approvals drive the adoption of advanced clot management technologies. For instance, in September 2024, The CLEANER VacTM Thrombectomy System, which is intended to remove blood clots from the peripheral venous vasculature, was introduced by Argon Medical Devices, a leading provider of medical device solutions for interventional radiology, vascular surgery, interventional cardiology, and oncology procedures. A single-use, large-bore aspiration tool called the CLEANER Vac Thrombectomy System was developed to quickly and effectively remove blood clots, also known as thrombus, from veins with restricted blood flow.

Favorable Healthcare Policies and Reimbursement Support

Supportive government policies and reimbursement frameworks create a positive clot management devices market outlook by making advanced clot management treatments more accessible. Many countries, including the United States, offer favorable insurance coverage for thrombectomy procedures, encouraging more hospitals and healthcare providers to adopt these technologies. Regulatory approvals from agencies like the FDA and CE mark certification for new clot management devices further drive market expansion. For instance, in March 2023, Penumbra received approval from the Food and Drug Administration to introduce Lightning Bolt 7, a revolutionary arterial thrombectomy system. The technology employs pressure sensors and an algorithm to determine whether the device is pulling in blood or a clot and modulates aspiration to remove blood clots. Penumbra, situated in Alameda, California, anticipates a 23% to 25% increase in sales in 2023 due to the Lightning Bolt 7 product and the recent introduction of Lightning Flash, another vascular device. Additionally, increasing healthcare expenditures and investments in medical infrastructure create opportunities for manufacturers to introduce innovative clot management solutions, ensuring broader patient access to life-saving treatments.

Clot Management Devices Industry Segmentation:

Analysis by Product Type:

  • Neurovascular Embolectomy Devices
  • Embolectomy Balloon Catheters
  • Percutaneous Thrombectomy Devices
    • Mechanical Thrombectomy
    • Aspiration Thrombectomy
    • Percutaneous Mechanical Thrombectomy (PMT)
  • Catheter-Directed Thrombolysis Devices
  • Inferior Vena Cava Filters
    • Permanent
    • Retrievable

Percutaneous thrombectomy devices stand as the largest product type in 2024, holding around 37.6% of the market due to their effectiveness in rapidly removing blood clots with minimal invasiveness. These devices are widely used in treating deep vein thrombosis, pulmonary embolism, and arterial thrombosis, reducing the risk of complications and improving patient outcomes. Advancements in technology have enhanced their precision and efficiency, making them a preferred choice among healthcare professionals. Additionally, the growing prevalence of cardiovascular diseases, an aging population, and increasing demand for faster recovery times further drive their adoption. Their ability to minimize hospital stays and healthcare costs also boosts market growth.

Analysis by End-User:

  • Hospitals
  • Diagnostic Centers and Specialty Clinics

Hospitals leads the market with around 80.9% of market share in 2024 due to their advanced infrastructure, skilled healthcare professionals, and ability to handle complex thrombectomy procedures. They offer a wide range of clot management treatments, including percutaneous thrombectomy, catheter-directed thrombolysis, and surgical thrombectomy, ensuring comprehensive patient care. The increasing prevalence of cardiovascular diseases and emergency cases requiring immediate clot removal further drive demand. Additionally, hospitals have better access to cutting-edge medical technologies and government funding, enhancing treatment efficiency. The rising number of hospital admissions for thrombotic disorders and the availability of reimbursement policies also contribute to their market dominance.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

In 2024, North America accounted for the largest market share of over 55.3%. The clot management devices demand in North America is influenced by the high prevalence of cardiovascular diseases, stroke, deep vein thrombosis, and pulmonary embolism. The region's advanced healthcare infrastructure, strong presence of key medical device manufacturers, and increasing adoption of minimally invasive procedures contribute to market growth. Favorable reimbursement policies, high healthcare spending, and government support for advanced medical technologies further enhance accessibility. Additionally, rising awareness of early clot detection and treatment, coupled with a growing geriatric population prone to thrombotic disorders, fuels demand. Technological advancements and an increasing number of outpatient procedures also play a significant role.

Key Regional Takeaways:

United States Clot Management Devices Market Analysis

In 2024, the United States accounted for over 89.80% of the clot management devices market in North America. The United States clot management devices market is primarily driven by the rising incidence of cardiovascular diseases, such as deep vein thrombosis (DVT), pulmonary embolism (PE), and stroke, driven by an increasing geriatric population and growing obesity rates. According to the Population Reference Bureau, the number of individuals aged 65 and above in the United States will reach 82 million by 2050, accounting for 23% of the population of the country. Moreover, the prevalence of atrial fibrillation, a key risk factor for thromboembolic events, is also rising, propelling the need for advanced clot removal solutions. Technological advancements in thrombectomy and embolectomy devices, such as catheter-directed thrombolysis and aspiration thrombectomy, are also improving procedural efficiency and patient outcomes, fueling adoption in hospitals and ambulatory surgical centers. Additionally, the growing preference for minimally invasive procedures over conventional surgical interventions is further contributing to industry expansion, as these devices reduce complications, hospital stays, and recovery times. Favorable reimbursement policies and guidelines from organizations such as the American Heart Association (AHA) and the U.S. Food and Drug Administration (FDA) further support the adoption of innovative clot management technologies. Besides this, expanding clinical research on novel clot management approaches is expected to further propel industry advancements.

Asia Pacific Clot Management Devices Market Analysis

The Asia Pacific clot management devices market is growing due to rising cases of atrial fibrillation and hypertension, both significant risk factors for thromboembolic disorders. Moreover, the increasing prevalence of cardiovascular diseases and venous thromboembolism (VTE), driven by aging populations, rising urbanization, and lifestyle-related risk factors such as diabetes, is also propelling the market. According to industry reports, 52.9% of the total population of Asia lived in urban areas in 2024, equating to 2,545,230,547 individuals. Additionally, rising awareness about stroke prevention and early treatment, driven by national health programs, is also encouraging the adoption of advanced clot removal technologies. Furthermore, the expansion of private healthcare facilities and the increasing presence of multinational medical device companies in emerging markets are improving access to cutting-edge thrombectomy and embolectomy solutions. Growing disposable incomes and improved insurance coverage are also making high-cost clot management procedures more accessible, supporting overall market growth.

Europe Clot Management Devices Market Analysis

The Europe clot management devices market is experiencing growth, fueled by the increasing prevalence of thromboembolic disorders, driven by aging demographics and sedentary lifestyles. The growing burden of non-communicable diseases, including hypertension, diabetes, and cardiovascular disorders, further elevates the risk of thromboembolic events. According to the World Health Organization (WHO), cardiovascular diseases (CVDs) account for more than 42.5% of all deaths each year in Europe, making them the leading cause of premature death in the region. The widespread implementation of national stroke prevention programs and guidelines by organizations such as the European Society of Cardiology (ESC) and the European Stroke Organisation (ESO) is driving the adoption of advanced thrombectomy and thrombolysis devices. Increasing healthcare investments across Europe, particularly in digital health integration and AI-powered clot detection technologies, is further improving diagnosis and treatment precision. Additionally, the rising number of stroke centers and specialized vascular care units across countries such as Germany, the UK, France, and Italy is also boosting demand for advanced clot management technologies. Increasing awareness campaigns and training programs for healthcare professionals on thromboembolic disease management are further driving adoption. The rise in surgical procedures, particularly orthopedic and cancer-related surgeries, is also leading to a higher incidence of post-operative blood clots, propelling the need for effective clot management solutions.

Latin America Clot Management Devices Market Analysis

The Latin America clot management devices market is expanding due to the increasing prevalence of hypertension and metabolic disorders, which elevate the risk of thromboembolic events. Growing healthcare expenditure and government initiatives aimed at improving stroke care are enhancing access to advanced thrombectomy and thrombolysis procedures. For instance, as per the International Trade Administration (ITA), 9.47% of the GDP of Brazil is spent on healthcare, making it the largest market for healthcare in Latin America. The expansion of private hospitals and specialized stroke centers, particularly in Brazil, Mexico, and Argentina, is further supporting market growth. According to the ITA, 62% of the hospitals in Brazil are private. Besides this, strengthening regulatory frameworks and faster approval processes are also facilitating the introduction of new clot removal technologies in the region.

Middle East and Africa Clot Management Devices Market Analysis

The Middle East and Africa clot management devices market is propelled by an increasing geriatric population and a higher incidence of risk factors such as hypertension and dyslipidemia, increasing the likelihood of thromboembolic events. Expanding health insurance coverage and government subsidies in countries such as Saudi Arabia and the UAE are improving access to advanced clot removal procedures. For instance, according to the International Trade Administration, the Saudi Arabian government intends to invest more than USD 65 billion under Vision 2030 to build the nation's healthcare system and restructure and privatize insurance and health care. Additionally, local manufacturing initiatives and partnerships with international medical device companies are improving product availability and affordability. Growing medical tourism in the region is further supporting the adoption of advanced clot management technologies.

Competitive Landscape:

The market for clot management devices is extremely competitive, and major competitors are concentrating on product improvements, strategic mergers, and technology breakthroughs to improve their market positions. Major companies like Medtronic, Boston Scientific, Terumo Corporation, and Abbott Laboratories dominate the industry with a broad product portfolio and global presence. Startups and mid-sized firms are also entering the market, introducing novel minimally invasive solutions. Collaborations with healthcare providers and research institutions drive innovation. Regulatory approvals, reimbursement policies, and clinical trial success significantly impact market dynamics. Companies compete based on product efficacy, pricing, and distribution networks, making innovation and strategic expansion crucial.

The report provides a comprehensive analysis of the competitive landscape in the clot management devices market with detailed profiles of all major companies, including:

  • AngioDynamics Inc.
  • Argon Medical Devices Inc.
  • Boston Scientific Corporation
  • DePuy Synthes Inc.
  • Edwards Lifesciences Corporation
  • iVascular S.L.U.
  • Lemaitre Vascular Inc.
  • Medtronic Inc.
  • Straub Medical AG
  • Stryker Corporation
  • Teleflex Incorporated
  • Vascular Solutions

Key Questions Answered in This Report

  • 1.How big is the clot management devices market?
  • 2.What is the future outlook of the clot management devices market?
  • 3.What are the key factors driving the clot management devices market?
  • 4.Which region accounts for the largest clot management devices market share?
  • 5.Which are the leading companies in the global clot management devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Clot Management Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Neurovascular Embolectomy Devices
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Embolectomy Balloon Catheters
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Percutaneous Thrombectomy Devices
    • 6.3.1 Market Trends
    • 6.3.2 Major Types
      • 6.3.2.1 Mechanical Thrombectomy
      • 6.3.2.2 Aspiration Thrombectomy
      • 6.3.2.3 Percutaneous Mechanical Thrombectomy (PMT)
    • 6.3.3 Market Forecast
  • 6.4 Catheter-Directed Thrombolysis Devices
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Inferior Vena Cava Filters
    • 6.5.1 Market Trends
    • 6.5.2 Major Types
      • 6.5.2.1 Permanent
      • 6.5.2.2 Retrievable
    • 6.5.3 Market Forecast

7 Market Breakup by End-User

  • 7.1 Hospitals
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Diagnostic Centers and Specialty Clinics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Indicators

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 AngioDynamics Inc.
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Argon Medical Devices Inc.
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 Boston Scientific Corporation
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 DePuy Synthes Inc.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
    • 13.3.5 Edwards Lifesciences Corporation
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
    • 13.3.6 iVascular S.L.U.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
    • 13.3.7 Lemaitre Vascular Inc.
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Medtronic Inc.
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
    • 13.3.9 Straub Medical AG
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
    • 13.3.10 Stryker Corporation
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis
    • 13.3.11 Teleflex Incorporated
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
      • 13.3.11.3 Financials
      • 13.3.11.4 SWOT Analysis
    • 13.3.12 Vascular Solutions
      • 13.3.12.1 Company Overview
      • 13.3.12.2 Product Portfolio